- Home
- RNXT vs TRIB Comparison
RNXT vs TRIB Comparison
Compare RNXT & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- TRIB
- Stock Information
- Founded
- RNXT 2012
- TRIB 1992
- Country
- RNXT United States
- TRIB Ireland
- Employees
- RNXT N/A
- TRIB N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RNXT Health Care
- TRIB Health Care
- Exchange
- RNXT Nasdaq
- TRIB Nasdaq
- Market Cap
- RNXT 30.0M
- TRIB 24.0M
- IPO Year
- RNXT 2021
- TRIB N/A
- Fundamental
- Price
- RNXT $1.27
- TRIB $0.81
- Analyst Decision
- RNXT Strong Buy
- TRIB
- Analyst Count
- RNXT 2
- TRIB 0
- Target Price
- RNXT $6.50
- TRIB N/A
- AVG Volume (30 Days)
- RNXT 118.6K
- TRIB 147.6K
- Earning Date
- RNXT 11-13-2024
- TRIB 11-15-2024
- Dividend Yield
- RNXT N/A
- TRIB N/A
- EPS Growth
- RNXT N/A
- TRIB N/A
- EPS
- RNXT N/A
- TRIB N/A
- Revenue
- RNXT N/A
- TRIB $59,126,000.00
- Revenue This Year
- RNXT N/A
- TRIB $11.63
- Revenue Next Year
- RNXT N/A
- TRIB $10.13
- P/E Ratio
- RNXT N/A
- TRIB N/A
- Revenue Growth
- RNXT N/A
- TRIB N/A
- 52 Week Low
- RNXT $0.68
- TRIB $0.75
- 52 Week High
- RNXT $2.35
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- RNXT 52.77
- TRIB 25.82
- Support Level
- RNXT $1.21
- TRIB $0.75
- Resistance Level
- RNXT $1.55
- TRIB $0.93
- Average True Range (ATR)
- RNXT 0.12
- TRIB 0.11
- MACD
- RNXT -0.02
- TRIB 0.00
- Stochastic Oscillator
- RNXT 32.20
- TRIB 13.00
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.